GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (OTCPK:LBLTF) » Definitions » Effective Interest Rate on Debt %

Lattice Biologics (Lattice Biologics) Effective Interest Rate on Debt % : 0.00% (As of Jun. 2021)


View and export this data going back to 2001. Start your Free Trial

What is Lattice Biologics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Lattice Biologics's annualized positive value of Interest Expense for the quarter that ended in Jun. 2021 was $0.00 Mil. Lattice Biologics's average total debt for the quarter that ended in Jun. 2021 was $0.00 Mil. Therefore, Lattice Biologics's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2021 was N/A%.


Lattice Biologics Effective Interest Rate on Debt % Historical Data

The historical data trend for Lattice Biologics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Effective Interest Rate on Debt % Chart

Lattice Biologics Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Sep16 Sep17 Sep18 Sep19 Sep20
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.76 17.81 21.06 26.17 39.50

Lattice Biologics Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.50 59.50 14.33 - -

Competitive Comparison of Lattice Biologics's Effective Interest Rate on Debt %

For the Medical Devices subindustry, Lattice Biologics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lattice Biologics's Effective Interest Rate on Debt % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lattice Biologics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Lattice Biologics's Effective Interest Rate on Debt % falls into.



Lattice Biologics Effective Interest Rate on Debt % Calculation

Lattice Biologics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Sep. 2020 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Sep. 2019 )+Total Debt  (A: Sep. 2020 ))/ count )
=-1  *  -1.04/( (2.131+3.135)/ 2 )
=-1  *  -1.04/2.633
=39.50 %

where

Total Debt  (A: Sep. 2019 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.203 + 1.928
=2.131

Total Debt  (A: Sep. 2020 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.888 + 2.247
=3.135

Lattice Biologics's annualized Effective Interest Rate on Debt % for the quarter that ended in Jun. 2021 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Mar. 2021 )+Total Debt  (Q: Jun. 2021 ))/ count )
=-1  *  0/( (0+0)/ 1 )
=-1  *  0/0
=N/A %

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jun. 2021) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Lattice Biologics  (OTCPK:LBLTF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Lattice Biologics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Lattice Biologics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lattice Biologics (Lattice Biologics) Business Description

Traded in Other Exchanges
N/A
Address
512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (Lattice Biologics) Headlines

No Headlines